Neurones (NRO) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
28 Jul, 2025Executive summary
Achieved double-digit organic growth in the third quarter of 2024, with notable advances in Data, Digital Projects, Cybersecurity, and Secure Cloud.
Financial highlights
Third quarter 2024 revenues reached €196.7 million, up 11.1% year-over-year, with organic growth at 10.5%.
Nine-month revenues totaled €599.1 million, a 9.8% increase year-over-year, with 8.9% organic growth.
Operating profit for the nine-month period was 9.6% of revenues, after including 0.8% of bonus share expenses.
Total turnover margin decreased to 14.3% from 17.3% a year ago.
Outlook and guidance
2024 forecasts reaffirmed: around €800 million in revenues and 9.5% operating profit expected.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Neurones
- 2025 revenue up 5.8%, operating margin at 10.4%, and dividend set to rise 7.7%.NRO
Q4 202511 Mar 2026 - Revenue up 5.8% to €857.2M in 2025, with strong digital, data, and AI growth.NRO
Q4 2025 TU11 Feb 2026 - Q3 2025 delivered 5.1% organic growth and improved margins, with robust digital segment gains.NRO
Q3 20255 Nov 2025 - Revenue up 5.4% to €424.3M; margin improved; FY guidance raised to €850M.NRO
Q2 202522 Sep 2025 - Organic growth of 5.3% in Q2 2025 drives raised full-year revenue guidance.NRO
Q2 2025 TU6 Aug 2025 - Revenue up 9.1% in H1 2024, with strong growth in Data and Cloud services.NRO
Q2 2024 TU28 Jul 2025 - Revenue up 9.1% in H1 2024; full-year guidance for €800m revenue and 9.5% margin reaffirmed.NRO
H1 202428 Jul 2025 - 2024 revenues grew 9.3% to €810.4M, surpassing forecasts with strong digital and cloud demand.NRO
Q4 2024 TU28 Jul 2025 - Revenue and net profit rose strongly, with robust cash flow and a higher dividend proposed.NRO
H2 202428 Jul 2025